This study evaluates the effects of stereotactic MR-guided adaptive radiotherapy (SMART) on early toxicity and tumor response in rectal cancer patients.
Twenty patients with locally advanced rectal cancer underwent SMART treatment with promising outcomes, as no severe adverse effects were noted and all patients experienced pathological downstaging.
The research concludes that SMART is a well-tolerated and effective treatment for rectal cancer, particularly when patients have a delay before surgery.